Intervention for Patients Intubated and Conscious to decrease Peritraumatic Distress (IPIC-PTD) – Acceptability and feasibility

Émilie, Gosselin; Gélinas, Céline; Bourgault, Patricia; Lavoie, Stéphan

doi:10.31770/2561-7516.1019

Cited by 5 publications

(8 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Physical functioning was the fourth most prominent domain ( n = 30, 8.6%), with studies examining effects of music interventions on pain (e.g., Gosselin et al, 2019 ) and sleep (e.g., Guétin et al, 2009 ; Blanaru et al, 2012 ). Global Quality of Life followed ( n = 35, 10.0%), often included as a second or third outcome.…”

Section: Resultsmentioning

confidence: 99%

“…Much earlier, Lehrer-Carle (1971) studied how group music therapy affected the ability of adolescents with schizophrenia to communicate with others and generate socially-valuable skills. Physical functioning was the fourth most prominent domain (n = 30, 8.6%), with studies examining effects of music interventions on pain (e.g., Gosselin et al, 2019) and sleep (e.g., Guétin et al, 2009;Blanaru et al, 2012). Global Quality of Life followed (n = 35, 10.0%), often included as a second or third outcome.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Use of Music in the Treatment and Management of Serious Mental Illness: A Global Scoping Review of the Literature

et al. 2021

View full text Add to dashboard Cite

Mental and substance use disorders have been identified as the leading cause of global disability, and the global burden of mental illness is concentrated among those experiencing disability due to serious mental illness (SMI). Music has been studied as a support for SMIs for decades, with promising results; however, a lack of synthesized evidence has precluded increased uptake of and access to music-based approaches. The purpose of this scoping review was to identify the types and quantity of research at intersections of music and SMIs, document evidentiary gaps and opportunities, and generate recommendations for improving research and practice. Studies were included if they reported on music's utilization in treating or mitigating symptoms related to five SMIs: schizophrenia, bipolar disorder, generalized anxiety disorder, major depressive disorder, or post-traumatic stress disorder. Eight databases were searched; screening resulted in 349 included studies for data extraction. Schizophrenia was the most studied SMI, with bipolar disorder studied the least. Demographics, settings, and activity details were found to be inconsistently and insufficiently reported; however, listening to recorded music emerged as the most common musical activity, and activity details appeared to have been affected by the conditions under study. RCTs were the predominant study design, and 271 unique measures were utilized across 289 primary studies. Over two-thirds of primary studies (68.5%) reported positive results, with 2.8% reporting worse results than the comparator, and 12% producing indeterminate results. A key finding is that evidence synthesis is precluded by insufficient reporting, widely varied outcomes and measures, and intervention complexity; as a result, widespread changes are necessary to reduce heterogeneity (as feasible), increase replicability and transferability, and improve understandings of mechanisms and causal pathways. To that end, five detailed recommendations are offered to support the sharing and development of information across disciplines.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

The Use of Music in the Treatment and Management of Serious Mental Illness: A Global Scoping Review of the Literature

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Patients with severe COVID-19 frequently present with respiratory symptoms which may progress to respiratory failure (Xie et al, 2020). Treatment for COVID-19 may involve extreme stressors for patients, including fear of death from life-threatening illness, pain from medical interventions such as endotracheal intubation, limited ability to communicate, and feelings of loss of control (Asimakopoulou & Madianos, 2014;Davydow et al, 2008;Gosselin et al, 2018). One patient described the sensation of COVID-19 respiratory infection as "it feels like you're drowning … you think you're going to die" (Buxbaum, 2020), and a respiratory therapist described shock at the severity of pink, frothy secretions occluding patient's breathing tubes (Presser, 2020).…”

Section: Near Death Experiencementioning

confidence: 99%

“…PTSS appear to be present in between 30 and 40% of ARDS survivors, even months after treatment (Mikkelsen et al, 2012;Shaw et al, 2001;Wade et al, 2013). More generally, estimates of PTSD in intubated and mechanically ventilated patients range from 14 to 51% (Gosselin et al, 2018). Among patients who require mechanical ventilation in the ICU, the most common symptoms include feelings of guilt, mood swings, sleep disturbance, and memories of panic and suffocation (Girard et al, 2007).…”

Section: Icu-related Traumamentioning

confidence: 99%

Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors

Kaseda

Levine

2020

The Clinical Neuropsychologist

146

116

View full text Add to dashboard Cite

Objective: SARS-CoV-2 infection and its oft-associated illness COVID-19 may lead to neuropsychological deficits, either through direct mechanisms (i.e., neurovirulance) or indirect mechanisms, most notably complications caused by the virus (e.g., stroke) or medical procedures (e.g., intubation). The history of past human coronavirus outbreaks resulting in similar health emergencies suggests there will be a substantial prevalence of post-traumatic stress disorder (PTSD) among COVID-19 survivors. To prepare neuropsychologists for the difficult task of differentiating PTSD-related from neuropathology-related deficits in the oncoming wave of COVID-19 survivors, we integrate research across a spectrum of related areas. Methods: Several areas of literature were reviewed: psychiatric, neurologic, and neuropathological outcomes of SARS and MERS patients; neurological outcomes in COVID-19 survivors; PTSD associated with procedures common to COVID-19 patients; and differentiating neuropsychological deficits due to PTSD from those due to acquired brain injuries in other patient groups. Conclusions: Heightened risk of PTSD occurred in MERS and SARS survivors. While data concerning COVID-19 is lacking, PTSD is known to occur in patient groups who undergo similar hospital courses, including ICU survivors, patients who are intubated and mechanically ventilated, and those that experience delirium. Research with patients who develop PTSD in the context of mild traumatic brain injury further suggests that PTSD may account for some or all of a patient's subjective cognitive complaints and neuropsychological test performance. Recommendations are provided for assessing PTSD in the context of COVID-19.

show abstract

“…Moreover, patients may be subject to physical pain from interventions such as endotracheal intubation, and extreme stressors owing to fear of death from a fatal illness, inability to communicate, and feelings of loss of control. Survivors may be also traumatized after witnessing the death of their family members [7][8][9]. Therefore, surviving COVID-19 illness would represent near-death or fatal illness experiences, that would be sufficient to develop PTSS.…”

Section: Introductionmentioning

confidence: 99%

Post-traumatic stress symptoms among an Egyptian sample of post-remission COVID-19 survivors: prevalence and sociodemographic and clinical correlates

Abdelghani

Hassan

Alsadik

et al. 2021

Middle East Curr Psychiatry

View full text Add to dashboard Cite

Background Given its global spread, the COVID-19 virus infection itself may be experienced as a traumatic and stressful event among survivors. The post-traumatic stress symptoms (PTSS) among those surviving the disease were under evaluated. This study aimed to identify and compare PTSS and associated correlates among COVID-19 survivors and control subjects. A cross-sectional design with a convenience sampling included a total of 85 adults who survived COVID-19 virus infection and 85 control subjects (matched for age, sex, education, and socioeconomic level) who were recruited from Zagazig University Hospitals, Sharkia Province, Egypt. The participants were interviewed using a semistructured demographic and clinical checklist, Structured Clinical Interview for DSM-5 Axis I Disorders (SCID-5), the Impact of Event Scale-Revised (IES-R), and the Hospital Anxiety Depression Scale (HADS). Results Approximately, 72% of COVID-19 survivors experienced moderate-to-severe PTSS (compared to 53% of control subjects). Individuals who survived the COVID-19 virus infection were more likely to have intensified hyperarousal symptoms (OR: 2.7, 95% CI: 1.7–4.4), with higher total IES-R scoring (OR: 1.03, 95% CI: 1.01–1.05). Among COVID-19 survivors, those who reported moderate-to-severe PTSS were likely to experience severe COVID-19 symptoms during their illness (OR: 4.1, 95% CI: 1.4–11.9). Conclusions PTSS was prevalent among COVID-19 survivors in Egypt. The hyperarousal symptoms were the most experienced ones. The symptom severity of COVID-19 virus infection predicted PTSS in COVID-19 survivors.

show abstract

Intervention for Patients Intubated and Conscious to decrease Peritraumatic Distress (IPIC-PTD) – Acceptability and feasibility

Cited by 5 publications

References 57 publications

The Use of Music in the Treatment and Management of Serious Mental Illness: A Global Scoping Review of the Literature

The Use of Music in the Treatment and Management of Serious Mental Illness: A Global Scoping Review of the Literature

Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors

Post-traumatic stress symptoms among an Egyptian sample of post-remission COVID-19 survivors: prevalence and sociodemographic and clinical correlates

Contact Info

Product

Resources

About